Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1996-04-18
1998-06-30
Kulkosky, Peter F.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424452, 424459, 424468, 424476, 424500, 514782, A61K 922, A61K 4730
Patent
active
057730253
ABSTRACT:
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. The sustained release oral solid dosage forms are useful in the treatment of hypertension in human patients.
REFERENCES:
patent: 3485847 (1969-12-01), Bossert et al.
patent: 3784684 (1974-01-01), Bossert et al.
patent: 4562069 (1985-12-01), Hegasy et al.
patent: 4665081 (1987-05-01), Doi et al.
patent: 4673564 (1987-06-01), Kawata et al.
patent: 4792452 (1988-12-01), Howard et al.
patent: 4803081 (1989-02-01), Falk et al.
patent: 4880623 (1989-11-01), Piergiogio et al.
patent: 4889723 (1989-12-01), Kim et al.
patent: 4894235 (1990-01-01), Kohne et al.
patent: 4973469 (1990-11-01), Mulligan et al.
patent: 4983593 (1991-01-01), Miyajima et al.
patent: 5007790 (1991-04-01), Shell
patent: 5015479 (1991-05-01), Mulligan et al.
patent: 5051263 (1991-09-01), Barry et al.
patent: 5108757 (1992-04-01), Erdos et al.
patent: 5110602 (1992-05-01), Kim et al.
patent: 5128142 (1992-07-01), Mulligan et al.
patent: 5145683 (1992-09-01), Rhodes
patent: 5160734 (1992-11-01), Ganesan et al.
patent: 5264446 (1993-11-01), Hegasy et al.
patent: 5439687 (1995-08-01), Compassi
patent: 5455046 (1995-10-01), Baichwal
patent: 5476654 (1995-12-01), Conte et al.
patent: 5554387 (1996-09-01), Baichwal
Chemcial Abstracts, vol. 104 (1986) Abstract 174662y.
Chemical Abstracts, vol. 99 (1983) Abstract 128360d.
Chemical Abstracts, vol. 92 (1980) Abstract 135278s.
Chemical Abstracts, vol. 92 (1980) Abstract 82429h.
Chemical Abstracts, vol. 77 (1972) Abstract 39130g.
Chemical Abstracts, vol. 70 (1969) Abstract 17133p.
Chemical Abstracts, vol. 98 (1983) Abstract 221832y.
Alderman, D.A., "A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms", Int. J. Pharm. Tech. & Prod. Mfg., vol. 5, pp. 1-9 (1984).
Haynes, R. Brain, M.D., et al., "Manipulation of the therapeutic regimen to improve compliance: Conceptions and misconceptions", Clinical Pharmacology and Therapeutics, vol. 22, No. 2, (Aug. 1977).
English translation of Japanese Patent Laid-Open-To-Public, publication No. 8/1986, publication date Jan. 6, 1986, Japanese Patent Application No. 118,789/1984; Japanese Patent Application date: Jun. 9, 1984.
Techniques of Solubilization of Drugs, edited by Samuel H. Yalkowsky, The Upjohn Company, pub. Marcel Dekker, Inc., New York and Basel, pp. 308-315 (1981).
McGinity, J.W., et al., "Dissolution and Uniformity Properties of Ordered Mixes Micronized Griseofulvin and a Directly Compressible Excipient", Drug Development and Industrial Pharmacy, vol. 11, No. 4, pp. 891-900 (1985).
Helbig, J., et al. "Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions", Pharmaceuticals, (Abstract-98:221837d), vol. 98, p. 63 (1983).
The Merck Index, pp. 848-849, 9th Ed. (1976).
"Crystallization and Granulation", Remington's Practice of Pharmacy, 9th Ed., Chapter XXVII, pp. 208-211.
Ritschel, Angewandte Biopharmazie, pp. 293-302 (1973).
Sugimoto, I., et al., "Dissolution and Absorption of Nifedipine From Nifedipine-Polyvinylpyrrolidone Coprecipitate", Drug Development and Industrial Pharmacy, vol. 6, No. 2, pp., 137-161 (1980).
Kleinbloesem, M., et al., "Nifedipine: Kinetics and dynamics in healthy subjects", Clin. Pharmacol. Ther., vol. 35, No. 6, pp. 742-749 (1984).
Ramsch, K., et al., "Pharmacokinetics and Metabolism of Nifedipine", Hypertension Supplement II, vol. 5, No. 4, Jul.-Aug. 18-24 (1983).
Edward Mendell Co. Inc.
Kulkosky Peter F.
LandOfFree
Sustained release heterodisperse hydrogel systems--amorphous dru does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release heterodisperse hydrogel systems--amorphous dru, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release heterodisperse hydrogel systems--amorphous dru will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1856269